Formulation and optimization of a sustained-release tablet of ketorolac tromethamine.

Abstract

The objective of our study was to formulate a sustained-release tablet of Ketorolac tromethamine, which is a nonsteroidal anti-inflammatory agent. A 2(3) full factorial design (8 runs) was selected. The variables studied were the amount of drug (30 and 40 mg), ratio of hydroxypropyl methylcellulose (HPMC)/sodium carboxymethylcellulose (NaCMC) (240/40 and… (More)

Topics

Cite this paper

@article{Vatsaraj2002FormulationAO, title={Formulation and optimization of a sustained-release tablet of ketorolac tromethamine.}, author={Neha B. Vatsaraj and Hossein Zia and Thomas William Needham}, journal={Drug delivery}, year={2002}, volume={9 3}, pages={153-9} }